14.06.2016 18:30:50

Press Release: MorphoSys AG : Publication pursuant to --26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution

MorphoSys AG / MorphoSys AG : Publication pursuant to --26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution . Processed and transmitted by Nasdaq OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

X Notification of Major Holdings or Correction of a notification of Major Holding published on (date of publication)

1. Details of issuer (name, address) MorphoSys AG Lena-Christ-Str. 48 82152 Martinsried/Planegg, Germany

2. Reason for notification (multiple reasons possible) X Acquisition/disposal of shares with voting rights Acquisition/disposal of instruments Change of breakdown of voting rights Other reason: Voluntary Group Disclosure

3. Details of person subject to the notification obligation

Name: City and country of registered office (if applicable): Flossbach von Storch SICAV Luxemburg, Luxemburg

4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.

5. Date on which threshold was crossed or reached: 07.06.2016

6. Total positions % of voting total rights total of number of attached to both in % voting shares (total % of voting rights through instruments (7.a. + rights of of 7.a.) (total of 7.b.1 + 7.b.2) 7.b.) issuer Resulting situation 4.94% 0% 4.94% 26537682 Previous notification (if applicable) 5.67% 0% 5.67%

7. Notified details of the resulting situation a. Voting rights attached to shares (Sec. 21, 22 WpHG) ISIN absolute in % direct indirect direct indirect (Sec. 21 WpHG) (Sec. 22 WpHG) (Sec. 21 WpHG) (Sec. 22 WpHG) DE0006632003 1310742 0 4.94% 0% % % Total 1310742 4.94%

b.1. Instruments according to Sec. 25 Abs. 1 Nr. 1 WpHG (please use annex in case of more than 3 instruments) Type of Expiration or Exercise or Voting rights Voting rights in % instrument maturity conversion absolute date period % % % Total %

b.2 Instruments according to Sec. 25 Abs. 1 Nr. 2 WpHG (please use annex in case of more than 3 instruments) Type of Expiration Exercise Cash or Voting Voting rights in % instrument or or physical rights maturity conversion settlement absolute date period % % % Total %

8. Information in relation to the person subject to the notification obligation (please tick the applicable box): [X] Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). [ ] Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity (please use annex in case of more than 4 undertakings; in this case please always provide only to BaFin also an organizational chart accompanying your notification): Name % of voting rights % of voting rights through instruments Total of both (if at least held 3% or more) (if at least held 5% or more) (if at least held 5% or more) % % % % % % % % % % % %

9. In case of proxy voting according to -- 22 Abs. 3 WpHG Date of general meeting: Holding position after general meeting: % (equals voting rights)

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: MorphoSys AG via Globenewswire

HUG#2020543

--- End of Message ---

MorphoSys AG

Lena-Christ-Str. 48 Martinsried / Munich Germany

WKN: 663200;ISIN: DE0006632003;Index:TECH All Share,CDAX,Prime All Share, TecDAX,HDAX,MIDCAP;

Listed: Freiverkehr in Börse Stuttgart,

Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,

Freiverkehr in Börse Berlin,

Freiverkehr in Börse Düsseldorf,

Freiverkehr in Bayerische Börse München,

Freiverkehr in Niedersächsische Börse zu Hannover,

Prime Standard in Frankfurter Wertpapierbörse,

Regulierter Markt in Frankfurter Wertpapierbörse;

http://www.morphosys.com (END) Dow Jones Newswires

   June 14, 2016 12:00 ET (16:00 GMT)- - 12 00 PM EDT 06-14-16

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Analysen zu MorphoSysmehr Analysen

06.05.24 MorphoSys Neutral UBS AG
30.04.24 MorphoSys Neutral UBS AG
16.02.24 MorphoSys Neutral UBS AG
07.02.24 MorphoSys Neutral UBS AG
07.02.24 MorphoSys Buy UBS AG
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 511,23 2,45%